RyR2 QQ2958 Genotype and Risk of Malignant Ventricular Arrhythmias

Table 5

Genotypic frequency of RyR2 Q2958R in the study population subgroups according to arrhythmias occurrence.

	Group I	Group II	value
Hypertensive patients ()
QQ	12 (24.0%)	0 (0%)	0.0001
QR	37 (74.0%)	56 (98.2%)
RR	1 (2.0%)	1 (1.8%)
Not hypertensive patients ()
QQ	2 (4.3%)	3 (4.2%)	1
QR	43 (93.5%)	68 (94.4%)
RR	1 (2.2%)	1 (1.4%)
Dyslipidemic patients ()
QQ	5 (11.9%)	6 (11.1%)	1
QR	36 (85.7%)	47 (87.0%)
RR	1 (2.4%)	1 (1.9%)
Not dyslipidemic patients ()
QQ	4 (7.4%)	3 (4.0%)	0.6777
QR	49 (90.8%)	71 (94.7%)
RR	1 (1.8%)	1 (1.3%)
Diabetic patients ()
QQ	6 (15.0%)	2 (4.0%)	0.0696
QR	33 (82.5%)	48 (96.0%)
RR	1 (2.5%)	0 (0%)
Not diabetic patients ()
QQ	8 (14.3%)	2 (2.5%)	0.0204
QR	47 (83.9%)	77 (95.0%)
RR	1 (1.8%)	2 (2.5%)

with Fisher’s exact test, while using Armitage trend test.